Clover Health Investments (CLOV) reports Q4 results; offers guidance
Clover Health Investments (NASDAQ: CLOV) reported Q4 Revenue for the quarter at $510.3 million versus the consensus estimate of $474.01 million.
GUIDANCE:
Clover Health Investments sees FY2024 Insurance revenue of $1.25-1.3 billion. Insurance MCR of 79% - 83%. Adjusted EBITDA (Non-GAAP) of ($20) million - $20 million
For earnings history and earnings-related data on Clover Health Investments (CLOV) click here.
